The primary safety outcome was the proportion of patients who discontinued therapy because of a drug-related adverse event, and a secondary measure was IOP reduction.

• 主要的药物安全试验结果，是患者因为药物相关的副作用而停止治疗，次要的测量则是IOP的降低量。